Micro Interventional Devices (MID) designs, manufactures and commercializes disruptive catheter-based technologies for the treatment of structural heart disease.

MID develops products for Transcatheter Cardiac Repair (TCR) percutaneously replicating surgical procedures with the aim of eliminating the need for open heart surgery!

The percutaneous replication of surgical procedures and elimination of the need for open heart surgery benefits the:

Patient: Through less invasive and less morbid procedures.

Surgeon/Interventionalist: Through technology that improves outcomes, reduces operative time and/or improves ease of use.

Healthcare Network: Through cost effective technologies that achieve superior outcomes while reducing procedure time.